Some of Medtronic's shareholders aren't pleased about the structure of the $43 billion mega-merger with Covidien, which will stick some long-time backers with significant fees.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/XEGqgm
Cap comentari:
Publica un comentari a l'entrada